Delirium in COVID-19 patients with ARDS: comparison with other etiologies

被引:0
|
作者
Bernard-Valnet, R. [1 ,2 ]
Favre, E. [2 ,3 ]
Bernini, A. [2 ,3 ]
Oddo, M. [2 ,4 ]
Du Pasquier, R. [1 ,2 ]
Chiche, J. [2 ,3 ]
Rossetti, A. [1 ,2 ]
机构
[1] CHU Vaudois, Neurol Serv, Dept Clin Neurosci, Lausanne Univ Hosp, Lausanne, Switzerland
[2] Univ Lausanne, Lausanne, Switzerland
[3] CHU Vaudois, Dept Intens Care Med, Lausanne Univ Hosp, Lausanne, Switzerland
[4] CHU Vaudois, Direct Med, Lausanne Univ Hosp, Lausanne, Switzerland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-009
引用
收藏
页码:174 / 174
页数:1
相关论文
共 50 条
  • [41] Delirium: A Frequent Manifestation in COVID-19 Older Patients
    Mattace-Raso, Francesco
    Polinder-Bos, Harmke
    Oosterwijk, Barbara
    van Bruchem-Visser, Rozemarijn
    Goudzwaard, Jeannette
    Oudshoorn, Christian
    Ziere, Gijsbertus
    Egberts, Angelique
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 2245 - 2247
  • [42] Schizophrenia and COVID-19 delirium
    Palomar-Ciria, Nora
    Blanco del Valle, Patricia
    Hernandez-Las Heras, Miguel Angel
    Martinez-Gallardo, Ricardo
    PSYCHIATRY RESEARCH, 2020, 290
  • [43] Delirium in the Era of COVID-19
    Byrnes, Tru
    Pate, Kimberly
    Cochran, Allyson R.
    Belin, Latasia
    JOURNAL OF NURSING CARE QUALITY, 2024, 39 (01) : 92 - 97
  • [44] Delirium and COVID-19 pandemic
    Kyziridis, T.
    ARCHIVES OF HELLENIC MEDICINE, 2023, 40 (03): : 423 - 426
  • [45] Utilization of antipsychotics for delirium after hospitalization for COVID-19 and other infections
    Bessette, Lily
    Zhang, Yichi
    York, Cassandra
    Lin, Joshua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 291 - 292
  • [46] RESPIRATORY PHYSIOLOGICAL PARAMETERS AND OUTCOMES OF PATIENTS WITH COVID-19 ARDS AND NON-COVID-19 ARDS UNDERGOING ECMO
    Federbush, M.
    Hasan, Z.
    Rodriguez, G.
    Varrone, M.
    Mundanchira, G.
    Manetta, F.
    Narasimhan, M.
    CHEST, 2022, 161 (06) : 502A - 502A
  • [47] Comparison of Host-Response Biomarkers and Inflammatory Subphenotypes in COVID-19 Without ARDS, COVID-ARDS, and Non-COVID-ARDS
    Drohan, C. M.
    Yang, H.
    Schaefer, C.
    Bensen, N.
    Lu, M.
    Methe, B.
    Qin, S.
    Zhang, Y.
    Lisius, G.
    Bain, W.
    Shah, F. A.
    Mcverry, B. J.
    Morris, A.
    Kitsios, G. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [48] Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients
    Hoechter, D. J.
    Becker-Pennrich, A.
    Langrehr, J.
    Bruegel, M.
    Zwissler, B.
    Schaefer, S.
    Spannagl, M.
    Hinske, L. C.
    Zoller, M.
    THROMBOSIS RESEARCH, 2020, 196 : 186 - 192
  • [49] Comparison of Fixed Dosing vs Train of Four Titration of Cisatracurium in COVID-19 ARDS Patients
    Banerjee, Oyshik
    Elefritz, Jessica L.
    Doepker, Bruce A.
    Atyia, Sara A.
    Brummel, Nathan E.
    Smith, Rachel M.
    Handley, Demond
    Cape, Kari M.
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (05) : 1082 - 1090
  • [50] COMPARISON OF COVID-19 PATIENTS ADMITTED TO THE HOSPITAL WITH ARDS AND THOSE WHO PROGRESS TO IT DURING HOSPITALIZATION
    Imran, Maryam
    Alzahrani, Mohammed
    Mulla, Nahid
    Mawlawi, Murad
    Alharbi, Azhar
    Nadhreen, Renad
    Qadah, Ahmed
    Binhashr, Mansor
    Yamani, Romaysaa
    Imran, Manahil
    Khalid, Tabindeh
    Khalid, Imran
    CHEST, 2021, 160 (04) : 1010A - 1011A